Related Experiment Video
Updated: May 26, 2026
05:30
Laparoscopic Radical Gastrectomy for Remnant Gastric Cancer
Published on: October 31, 2025
[Cancer incidence in the military: an update]
Mario Stefano Peragallo1, Francesco Urbano, Giuseppe Sarnicola
1Centro studi e ricerche di sanità e di veterinaria dell'esercito. mario.peragallo@ esercito.difesa.it
Epidemiologia E Prevenzione
|December 15, 2011
Summary
Cancer surveillance in Italian soldiers revealed no increased Hodgkin
Area of Science:
- Military epidemiology
- Cancer surveillance systems
- Public health
Background:
- A 2001 report indicated elevated Hodgkin's lymphoma rates in Italian soldiers deployed in Bosnia and Kosovo.
- A surveillance system was established for the military community to monitor cancer incidence.
- Previous studies suggested potential cancer risks associated with military deployments.
Purpose of the Study:
- To assess cancer incidence among Italian military personnel.
- To investigate the reported excess of Hodgkin's lymphoma.
- To evaluate the overall cancer risk in the military community.
Main Methods:
- Analysis of cancer surveillance data from 1996-2007 for Italian military personnel.
- Comparison of observed cancer cases with expected rates.
- Estimation of incident cases, accounting for potential underreporting.
Main Results:
- Overall cancer incidence rates were lower than expected.
- No significant difference was found in Hodgkin's lymphoma rates compared to expected.
- A significant excess of thyroid cancer was observed, likely due to selection bias.
Conclusions:
- The elevated Hodgkin's lymphoma rate was likely a chance event, unrelated to deployment.
- The observed excess of thyroid cancer may be attributed to selection bias.
- Comprehensive cancer assessment requires improved data linkage between military and national health records.
Related Concept Videos
01:21Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
02:18Cancer
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:59Cancer Prevention
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...